Patients with good collateralization may profit from cilostazol

Cardiology (Switzerland)

Volumn 123, Issue 3, 2012, Pages 142-

  Meier, Pascal ^a   Indermuehle, Andreas ^a   Timmis, Adam ^b  

^a UNIVERSITY COLLEGE LONDON HOSPITALS   (United Kingdom)

^b LONDON CHEST HOSPITAL   (United Kingdom)

Author keywords

[No Author keywords available]

Indexed keywords

CILOSTAZOL; RAPAMYCIN;

BARE METAL STENT; CORONARY ARTERY COLLATERAL CIRCULATION; CORONARY ARTERY PRESSURE; DRUG ELUTING STENT; HUMAN; IN-STENT RESTENOSIS; LETTER; META ANALYSIS (TOPIC); PRIORITY JOURNAL; PROGNOSIS; RISK REDUCTION; SMOOTH MUSCLE FIBER; SYSTEMATIC REVIEW (TOPIC);

CORONARY RESTENOSIS; FEMALE; HUMANS; MALE; PERCUTANEOUS CORONARY INTERVENTION; PLATELET AGGREGATION INHIBITORS; STENTS; TETRAZOLES;

EID: 84870664142     PISSN: 00086312     EISSN: 14219751     Source Type: Journal    
DOI: 10.1159/000342276     Document Type: Letter

References (7)

1. Jang JS, Jin HY, Seo JS, Yang TH, Kim DK, Kim DS, Seol SH, Kim DI, Cho KI, Kim BH, Park YH, Je HG, Jeong YH, Kim WJ, Lee JY, Lee SW: A meta-analysis of randomized controlled trials appraising the efficacy and safety of cilostazol after coronary artery stent implantation. Cardiology 2012; 122: 133-143.
2. Saunamaki KI: Systemic drugs for restenosis prevention: old idea, new drugs. Cardiology 2010; 115: 75-76.
3. Cernigliaro C, Sansa M, Vitrella G, Verde A, Bongo AS, Giuliani L, Novelli E: Preventing restenosis after implantation of bare stents with oral rapamycin: a randomized angiographic and intravascular ultrasound study with a 5-year clinical follow-up. Cardiology 2010; 115: 77-86.
4. Danenberg HD: Prior bare metal stent restenosis as a predictor for subsequent restenosis: the lightning often strikes twice. Cardiology 2010; 116: 188-189.
5. Henderson RA, Timmis AD: Almanac 2011: stable coronary artery disease-an editorial overview of selected research that has driven recent advances in clinical cardiology. Heart 2011; 97: 1552-1559.
6. Meier P, Indermuehle A, Pitt B, Traupe T, de Marchi SF, Crake T, Knapp G, Lansky AJ, Seiler C: Coronary collaterals and risk for restenosis after percutaneous coronary interventions: a meta-analysis. BMC Med 2012; 10: 62.
7. Park KW, Park JJ, Lee SP, Oh IY, Suh JW, Yang HM, Lee HY, Kang HJ, Cho YS, Koo BK, Youn TJ, Chae IH, Choi DJ, Oh BH, Park YB, Kim HS: Cilostazol attenuates on-treatment platelet reactivity in patients with CYP2C19 loss of function alleles receiving dual antiplatelet therapy: a genetic substudy of the CILON-T randomised controlled trial. Heart 2011; 97: 641-647.